US Market News
2月前
SS&C Technologies Releases Q1 2026 Financial ResultsApril 23, 2026 4:05 PM
Business Wire
Q1 2026 GAAP revenue $1,647.1 million, up 8.8%, Fully Diluted GAAP Earnings Per Share $0.91, up 8.3%
Adjusted revenue $1,648.2 million, up 8.8%, Adjusted Diluted Earnings Per Share $1.69, up 14.2%
SS&C Technologies Holdings, Inc. (NASDAQ: SSNC), a global provider of investment, financial and healthcare software and technology-enabled services, today announced its financial results for the first quarter ended March 31, 2026.
Three Months Ended March 31,
(in millions, except per share data):
2026
2025
Change
GAAP Results
Revenue
$1,647.1
$1,513.9
8.8%
Operating income
398.2
357.9
11.3%
Operating income margin
24.2%
23.6%
60 bps
Net income
226.1
213.0
6.2%
Diluted earnings per share
$0.91
$0.84
8.3%
Adjusted Non-GAAP Results (defined in Notes 1 - 4 below)
Adjusted revenue
$1,648.2
$1,514.8
8.8%
Adjusted operating income
633.6
575.3
10.1%
Adjusted operating income margin
38.4%
38.0%
40 bps
Adjusted consolidated EBITDA
651.0
591.9
10.0%
Adjusted consolidated EBITDA margin
39.5%
39.1%
40 bps
Adjusted diluted earnings per share(1)
$1.69
$1.48
14.2%
(1) Reflects non-GAAP tax rates of 22.5% and 22.0% for the three months ended March 31, 2026 and 2025, respectively. See Note 4 for more information.
First Quarter 2026 Highlights:
Q1 2026 GAAP Revenue growth and Adjusted Revenue growth were 8.8 percent.
Q1 2026 Adjusted Organic Revenue Growth was 5.0 percent.
Net cash generated from operating activities of $299.7 million for the three months ended March 31, 2026, up 10.1 percent compared to the same period in 2025.
Returned $233.3 million to shareholders in Q1 2026, which included 2.3 million shares repurchased for $168.0 million and $65.3 million in common stock dividends.
Adjusted consolidated EBITDA of $651.0 million for Q1 2026, up 10.0 percent. Adjusted consolidated EBITDA margin for Q1 2026 was 39.5 percent.
GAAP operating income margin for Q1 2026 was 24.2 percent and GAAP net income of $226.1 million for Q1 2026, up 6.2 percent.
Adjusted diluted earnings per share was $1.69, up 14.2 percent.
SS&C is launching Blue Prism WorkHQ, our AI orchestration platform, on April 28, 2026. Virtual registration is available at www.blueprism.com.
“As we mark 40 years of delivering mission-critical systems and processing, SS&C's strong first quarter results of $1,648 million adjusted revenues and $651 million adjusted consolidated EBITDA reflect our deeply embedded infrastructure and long-standing client relationships,” says Bill Stone, Chairman and Chief Executive Officer. “As AI reshapes enterprise technology, our role as a system of record and our global scale position us to adopt innovation thoughtfully, enhancing how our platforms operate.”
Operating Cash Flow
SS&C generated net cash from operating activities of $299.7 million for the three months ended March 31, 2026, compared to $272.2 million for the same period in 2025, a 10.1% increase. SS&C ended the first quarter with $420.9 million in cash and cash equivalents and $7,468.6 million in gross debt. SS&C’s consolidated net leverage ratio as defined in our credit agreement stood at 2.76 times consolidated EBITDA as of March 31, 2026. SS&C’s net secured leverage ratio stood at 1.69 times consolidated EBITDA as of March 31, 2026.
Guidance
Q2 2026
FY 2026
Adjusted Revenue ($M)
$1,640 – $1,680
$6,664 – $6,824
Adjusted Net Income ($M)
$408 – $424
$1,665 – $1,765
Interest Expense1 ($M)
$102 – $104
$401 – $411
Adjusted Diluted Earnings per Share
$1.64 – $1.70
$6.74 – $7.06
Cash from Operating Activities ($M)
–
$1,713 – $1,813
Capital Expenditures (% of revenue)
–
4.4% – 4.8%
Diluted Shares (M)
247.5 – 250.5
245.6 – 251.6
Effective Income Tax Rate (%)
21.5% – 23.5%
21.5% – 23.5%
1Interest expense is net of deferred financing cost amortization and original issue discount
SS&C does not provide reconciliations of guidance for Adjusted Revenues and Adjusted Net Income to comparable GAAP measures, in reliance on the unreasonable efforts exception provided under Item 10(e)(1)(i)(B) of Regulation S-K. SS&C is unable, without unreasonable efforts, to forecast certain items required to develop meaningful comparable GAAP financial measures. These items include acquisition transactions and integration, foreign exchange rate changes, as well as other non-cash and other adjustments as defined under the Company’s Credit agreement, that are difficult to predict in advance in order to include in a GAAP estimate. The unavailable information could have a significant impact on Q2 2026 and FY 2026 GAAP financial results.
Non-GAAP Financial Measures
Adjusted revenue, adjusted operating income, adjusted consolidated EBITDA, adjusted net income and adjusted diluted earnings per share are non-GAAP measures. See the accompanying notes for the reconciliations and definitions for each of these non-GAAP measures and the reasons our management believes these measures provide useful information to investors regarding our financial condition and results of operations. All references above to net income, diluted earnings per share, adjusted operating income, adjusted consolidated EBITDA, and adjusted diluted earnings per share are attributable to SS&C.
Earnings Call and Press Release
SS&C’s first quarter 2026 earnings call will take place at 5:00 p.m. eastern time today, April 23, 2026. The call will discuss first quarter 2026 results. Interested parties may visit investor.ssctech.com to access the live webcast and view accompanying slides. The call will be available for replay via the webcast on SS&C’s website; access: https://investor.ssctech.com/financials/quarterly-results/default.aspx
Certain information contained in this press release, including information relating to, among other things, the Company’s financial guidance for the second quarter and full year of 2026 constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, expectations, intentions, projections, developments, future events, performance, underlying assumptions, and other statements that are other than statements of historical facts. Without limiting the foregoing, the words “believes”, “anticipates”, “plans”, “expects”, “estimates”, “projects”, “forecasts”, “may”, “assume”, “intend”, “will”, “continue”, “opportunity”, “predict”, “potential”, “future”, “guarantee”, “likely”, “target”, “indicate”, “would”, “could” and “should” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements are accompanied by such words. Such statements reflect management’s best judgment based on factors currently known but are subject to risks and uncertainties, which could cause actual results to differ materially from those anticipated. Such risks and uncertainties include, but are not limited to, the state of the economy and the financial services industry and other industries in which the Company’s clients operate, the Company’s ability to realize anticipated benefits from its acquisitions, the effect of customer consolidation on demand for the Company’s products and services, the variability of revenue as a result of activity in the securities markets, the focus of the Company’s business on the asset management industry, the ability to retain and attract clients, the intensity of competition with respect to the Company’s products and services, risks from cyber-attacks, breaches of digital security, IT system failures and network disruptions, risks associated with third party providers, fluctuations in the Company’s operating results, terrorist activities and other catastrophic events, risks associated with the Company’s foreign operations, privacy concerns relating to the collection and storage of personal information, evolving regulations and increased scrutiny from regulators, the Company’s ability to protect intellectual property assets and litigation regarding intellectual property rights, delays in product development, investment decisions concerning cash balances, tax risks, risks associated with the Company’s joint ventures, changes in accounting standards, evolving regulation and scrutiny from regulators, the Company’s exposure to litigation and other claims, risks related to the Company’s substantial indebtedness, and the market price of the Company’s stock prevailing from time to time, and the risks discussed in the “Risk Factors” section of the Company’s most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, which are on file with the Securities and Exchange Commission and can also be accessed on our website. Such “Risk Factors”, among others, could cause actual results to differ materially from those indicated by forward-looking statements made herein and presented elsewhere by management from time to time. Undue reliance should not be placed on any such forward-looking statements. Forward-looking statements speak only as of the date on which they are made and, except to the extent required by applicable securities laws, we undertake no obligation to update or revise any forward-looking statements.
About SS&C Technologies
SS&C is a global provider of services and software for the financial services and healthcare industries. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has offices around the world. More than 23,000 financial services and healthcare organizations, from the world's largest companies to small and mid-market firms, rely on SS&C for expertise, scale, and technology.
Follow SS&C on X, LinkedIn and Facebook.
SS&C Technologies Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Comprehensive Income
(in millions, except per share data)
(unaudited)
Three Months Ended March 31,
2026
2025
Revenues:
Technology-enabled services
$
1,407.3
$
1,269.9
License, maintenance and related
239.8
244.0
Total revenues
1,647.1
1,513.9
Cost of revenues:
Technology-enabled services
740.5
667.3
License, maintenance and related
104.8
99.5
Total cost of revenues
845.3
766.8
Gross profit
801.8
747.1
Operating expenses:
Selling and marketing
151.7
152.3
Research and development
134.6
129.1
General and administrative
117.3
107.8
Total operating expenses
403.6
389.2
Operating income
398.2
357.9
Interest expense, net
(105.4
)
(105.2
)
Other income, net
6.8
7.2
Equity in earnings of unconsolidated affiliates, net
3.9
2.3
Loss on extinguishment of debt
(0.4
)
(0.9
)
Income before income taxes
303.1
261.3
Provision for income taxes
76.8
48.1
Net income
226.3
213.2
Net income attributable to noncontrolling interest
(0.2
)
(0.2
)
Net income attributable to SS&C common stockholders
$
226.1
$
213.0
Basic earnings per share attributable to SS&C common stockholders
$
0.94
$
0.87
Diluted earnings per share attributable to SS&C common stockholders
$
0.91
$
0.84
Basic weighted-average number of common shares outstanding
241.5
245.8
Diluted weighted-average number of common and common equivalent shares outstanding
247.6
254.9
Net income
$
226.3
$
213.2
Other comprehensive (loss) income, net of tax:
Foreign currency exchange translation adjustment
(72.1
)
92.5
Change in defined benefit pension obligation
0.4
—
Total other comprehensive (loss) income, net of tax
(71.7
)
92.5
Comprehensive income
154.6
305.7
Comprehensive income attributable to noncontrolling interest
(0.2
)
(0.2
)
Comprehensive income attributable to SS&C common stockholders
$
154.4
$
305.5
SS&C Technologies Holdings, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in millions)
(unaudited)
March 31,
December 31,
2026
2025
Assets
Current assets:
Cash and cash equivalents
$
420.9
$
462.1
Funds receivable and funds held on behalf of clients
3,617.5
3,799.5
Accounts receivable, net
1,021.0
978.7
Contract asset
50.3
49.2
Prepaid expenses and other current assets
231.2
193.7
Restricted cash
2.7
4.5
Total current assets
5,343.6
5,487.7
Property, plant and equipment, net
279.1
289.5
Operating lease right-of-use assets
219.8
233.3
Investments
172.8
174.4
Unconsolidated affiliates
294.7
307.7
Contract asset
128.7
133.1
Goodwill
9,932.4
9,991.3
Intangible and other assets, net
3,956.6
4,094.7
Total assets
$
20,327.7
$
20,711.7
Liabilities and Equity
Current liabilities:
Current portion of long-term debt
$
110.0
$
25.0
Client funds obligations
3,617.5
3,799.5
Accounts payable
92.0
87.2
Income taxes payable
55.4
23.3
Accrued employee compensation and benefits
202.9
348.9
Interest payable
16.4
31.6
Other accrued expenses
271.1
303.4
Deferred revenue
509.9
492.4
Total current liabilities
4,875.2
5,111.3
Long-term debt, net of current portion
7,320.5
7,408.4
Operating lease liabilities
202.9
213.2
Other long-term liabilities
195.3
190.2
Deferred income taxes
836.3
846.8
Total liabilities
13,430.2
13,769.9
SS&C stockholders' equity
6,843.1
6,887.6
Noncontrolling interest
54.4
54.2
Total equity
6,897.5
6,941.8
Total liabilities and equity
$
20,327.7
$
20,711.7
SS&C Technologies Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(in millions)
(unaudited)
Three Months Ended March 31,
2026
2025
Cash flow from operating activities:
Net income
$
226.3
$
213.2
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
181.0
170.8
Equity in earnings of unconsolidated affiliates, net
(3.9
)
(2.3
)
Distributions received from unconsolidated affiliates
16.9
—
Stock-based compensation expense
61.7
52.7
Unrealized net losses on investments
0.6
1.8
Amortization of debt financing costs
1.9
1.7
Loss on extinguishment of debt
0.4
0.9
Deferred income taxes
(6.6
)
(24.6
)
Provision for credit losses
5.7
5.3
Changes in operating assets and liabilities, excluding effects from acquisitions:
Accounts receivable
(50.6
)
(33.2
)
Prepaid expenses and other assets
(40.8
)
(4.6
)
Contract assets
3.5
(14.1
)
Accounts payable
(0.1
)
(11.4
)
Accrued expenses and other liabilities
(174.1
)
(137.0
)
Income taxes prepaid and payable
58.3
47.6
Deferred revenue
19.5
5.4
Net cash provided by operating activities
299.7
272.2
Cash flow from investing activities:
Business acquisitions, net of cash acquired
(0.2
)
(6.2
)
Additions to property and equipment
(6.0
)
(12.7
)
Additions to capitalized software
(62.0
)
(47.0
)
Investments in securities
(7.6
)
—
Proceeds from sales / maturities of investments
7.6
0.1
Collection of other non-current receivables
2.7
2.5
Net cash used in investing activities
(65.5
)
(63.3
)
Cash flow from financing activities:
Cash received from debt borrowings
160.0
20.0
Repayments of debt
(165.0
)
(175.0
)
Net (decrease) increase in client funds obligations
(470.2
)
1,200.4
Proceeds from exercise of stock options
22.3
201.8
Withholding taxes paid related to equity award net share settlement
(54.9
)
(43.4
)
Purchases of common stock for treasury
(168.0
)
(206.9
)
Dividends paid on common stock
(65.3
)
(61.6
)
Net cash (used in) provided by financing activities
(741.1
)
935.3
Effect of exchange rate changes on cash, cash equivalents and restricted cash
(6.4
)
3.9
Net (decrease) increase in cash, cash equivalents and restricted cash
(513.3
)
1,148.1
Cash, cash equivalents and restricted cash and cash equivalents, beginning of period
3,573.8
3,370.5
Cash, cash equivalents and restricted cash and cash equivalents, end of period
$
3,060.5
$
4,518.6
Reconciliation of cash, cash equivalents and restricted cash and cash equivalents:
Cash and cash equivalents
$
420.9
$
515.0
Restricted cash and cash equivalents
2.7
3.5
Restricted cash and cash equivalents included in funds receivable and funds held on behalf of clients
2,636.9
4,000.1
$
3,060.5
$
4,518.6
SS&C Technologies Holdings, Inc. and Subsidiaries
Disclosures Relating to Non-GAAP Financial Measures
Note 1. Reconciliation of Revenues to Adjusted Revenues
Adjusted revenues represents revenues adjusted to include a) amounts that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisition and b) amounts that would have been recognized if not for adjustments to deferred revenue and retained earnings related to the adoption of ASC 606. Adjusted revenues is presented because we use this measure to evaluate performance of our business against prior periods and believe it is a useful indicator of the underlying performance of our business. Adjusted revenues is not a recognized term under generally accepted accounting principles (“GAAP”). Adjusted revenues does not represent revenues, as that term is defined under GAAP, and should not be considered as an alternative to revenues as an indicator of our operating performance. Adjusted revenues as presented herein is not necessarily comparable to similarly titled measures presented by other companies. Below is a reconciliation of adjusted revenues to revenues, the GAAP measure we believe to be most directly comparable to adjusted revenues.
Three Months Ended March 31,
(in millions)
2026
2025
Revenues
$
1,647.1
$
1,513.9
Purchase accounting adjustments impact on revenue
1.1
0.9
Adjusted revenues
$
1,648.2
$
1,514.8
The following is a breakdown of technology-enabled services and license, maintenance and related revenues and adjusted technology-enabled services and license, maintenance and related revenues.
Three Months Ended March 31,
(in millions)
2026
2025
Technology-enabled services
$
1,407.3
$
1,269.9
License, maintenance and related
239.8
244.0
Total revenues
$
1,647.1
$
1,513.9
Technology-enabled services
$
1,408.4
$
1,270.8
License, maintenance and related
239.8
244.0
Total adjusted revenues
$
1,648.2
$
1,514.8
Note 2. Reconciliation of Operating Income to Adjusted Operating Income
Adjusted operating income represents operating income adjusted for amortization of intangible assets, stock-based compensation, purchase accounting adjustments for deferred revenue and related costs, ASC 606 adoption impact and other expenses. Adjusted operating income is presented because we use this measure to evaluate performance of our business and believe it is a useful indicator of our underlying performance. Adjusted operating income is not a recognized term under GAAP. Adjusted operating income does not represent operating income, as that term is defined under GAAP, and should not be considered as an alternative to operating income as an indicator of our operating performance. Adjusted operating income as presented herein is not necessarily comparable to similarly titled measures by other companies. The following is a reconciliation between adjusted operating income and operating income, the GAAP measure we believe to be most directly comparable to adjusted operating income.
Three Months Ended March 31,
(in millions)
2026
2025
Operating income
$
398.2
$
357.9
Amortization of intangible assets
162.9
153.0
Stock-based compensation
61.7
52.7
Purchase accounting adjustments (1)
1.8
2.1
ASC 606 adoption impact
0.1
0.1
Acquisition related (2)
0.9
1.3
Facilities and workforce restructuring
9.2
7.1
Other (3)
—
2.1
Adjusted operating income
$
634.8
$
576.3
Adjusted operating income attributable to noncontrolling interest (4)
(1.2
)
(1.0
)
Adjusted operating income attributable to SS&C common stockholders
$
633.6
$
575.3
(1)
Purchase accounting adjustments include (a) an adjustment to increase revenues by the amount that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisition, (b) an adjustment to increase personnel and commissions expense by the amount that would have been recognized if prepaid commissions and deferred personnel costs were not adjusted to fair value at the date of the acquisitions and (c) an adjustment to decrease depreciation expense by the amount that would not have been recognized if property, plant and equipment were not adjusted to fair value at the date of acquisition.
(2)
Acquisition related includes costs related to both current acquisitions and the resolution of pre-acquisition matters for prior period acquisitions.
(3)
Other includes additional expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance.
(4)
In 2021, we entered into a joint venture named DomaniRx, LLC in which we are the majority interest holder and primary beneficiary. As such, we consolidate DomaniRx, LLC as a variable interest entity. Adjusted operating income attributable to noncontrolling interest represents adjusted operating income based on the ownership interest retained by the respective noncontrolling parties.
Note 3. Reconciliation of Net Income to EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA
EBITDA represents net income before interest expense, income taxes, depreciation and amortization. Consolidated EBITDA, defined under our Credit Agreement entered into in April 2018, as amended, is used in calculating covenant compliance, and is EBITDA adjusted for certain items. Consolidated EBITDA is calculated by subtracting from or adding to EBITDA items of income or expense described below. Adjusted Consolidated EBITDA is calculated by subtracting acquired EBITDA (as defined below) from Consolidated EBITDA. EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA are presented because we use these measures to evaluate performance of our business and believe them to be useful indicators of an entity’s debt capacity and its ability to service debt. EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA are not recognized terms under GAAP and should not be considered in isolation or as alternatives to operating income, net income or cash flows from operating activities as indicators of our operating performance. These measures are not necessarily comparable to similarly titled measures by other companies. The following is a reconciliation of EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA to net income.
Three Months Ended March 31,
Twelve Months Ended March 31,
(in millions)
2026
2025
2026
Net income
$
226.3
$
213.2
$
811.8
Interest expense, net
105.4
105.2
426.4
Provision for income taxes
76.8
48.1
204.9
Depreciation and amortization
181.0
170.8
714.0
EBITDA
589.5
537.3
2,157.1
Stock-based compensation
61.7
52.7
266.6
Acquired EBITDA and cost savings (1)
—
—
31.4
Loss on extinguishment of debt
0.4
0.9
2.8
Equity in earnings of unconsolidated affiliates, net
(3.9
)
(2.3
)
7.7
Purchase accounting adjustments (2)
1.1
1.0
4.5
ASC 606 adoption impact
0.1
0.1
0.4
Foreign currency translation losses
1.4
2.2
1.0
Investment gains (3)
(8.7
)
(9.3
)
(13.4
)
Facilities and workforce restructuring
9.2
7.1
47.2
Acquisition related (4)
0.9
1.3
11.2
Other (5)
0.5
1.9
39.8
Consolidated EBITDA
$
652.2
$
592.9
$
2,556.3
Acquired EBITDA and cost savings (1)
—
—
(31.4
)
Adjusted Consolidated EBITDA
$
652.2
$
592.9
$
2,524.9
Adjusted Consolidated EBITDA attributable to noncontrolling interest (6)
(1.2
)
(1.0
)
(3.5
)
Adjusted Consolidated EBITDA attributable to SS&C common stockholders
$
651.0
$
591.9
$
2,521.4
(1)
Acquired EBITDA reflects the EBITDA impact of significant businesses that were acquired during the last twelve months as if the acquisition occurred at the beginning of the trailing twelve-month period, as well as cost savings enacted in connection with acquisitions.
(2)
Purchase accounting adjustments include (a) an adjustment to increase revenues by the amount that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisitions (b) an adjustment to increase personnel and commissions expense by the amount that would have been recognized if prepaid commissions and deferred personnel costs were not adjusted to fair value at the date of the acquisitions and (c) an adjustment to increase or decrease rent expense by the amount that would have been recognized if lease obligations were not adjusted to fair value at the date of acquisitions.
(3)
Investment gains includes unrealized fair value adjustments of investments and dividend income received on investments.
(4)
Acquisition related includes costs related to both current acquisitions and the resolution of pre-acquisition matters for prior period acquisitions.
(5)
Other includes additional expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance, and includes a loss on the sale of fixed assets of $33.3 million during the twelve months ended March 31, 2026.
(6)
In 2021, we entered into a joint venture named DomaniRx, LLC in which we are the majority interest holder and primary beneficiary. As such, we consolidate DomaniRx, LLC as a variable interest entity. Adjusted Consolidated EBITDA attributable to noncontrolling interest represents adjusted Consolidated EBITDA based on the ownership interest retained by the respective noncontrolling parties.
Note 4. Reconciliation of Net Income to Adjusted Net Income and Diluted Earnings Per Share Attributable to SS&C to Adjusted Diluted Earnings Per Share Attributable to SS&C
Adjusted net income and adjusted diluted earnings per share attributable to SS&C represent net income and earnings per share attributable to SS&C before amortization of intangible assets and deferred financing costs, stock-based compensation, purchase accounting adjustments and other items. We consider adjusted net income and adjusted diluted earnings per share attributable to SS&C to be important to management and investors because they represent our operational performance exclusive of the effects of amortization of intangible assets and deferred financing costs, stock-based compensation, purchase accounting adjustments, loss on extinguishment of debt and other items, that are not operational in nature or comparable to those of our competitors. Adjusted net income and adjusted diluted earnings per share are not recognized terms under GAAP. Adjusted net income and adjusted diluted earnings per share do not represent net income or diluted earnings per share, as those terms are defined under GAAP, and should not be considered as alternatives to net income or diluted earnings per share as indicators of our operating performance. Adjusted net income and adjusted diluted earnings per share attributable to SS&C as presented herein are not necessarily comparable to similarly titled measures presented by other companies. Below is a reconciliation of adjusted net income and adjusted diluted earnings per share attributable to SS&C to net income and diluted earnings per share attributable to SS&C, the GAAP measures we believe to be most directly comparable to adjusted net income and adjusted diluted earnings per share.
Three Months Ended March 31,
(in millions, except per share data)
2026
2025
GAAP – Net income
$
226.3
$
213.2
Amortization of intangible assets
162.9
153.0
Amortization of debt financing costs
1.9
1.7
Stock-based compensation
61.7
52.7
Loss on extinguishment of debt
0.4
0.9
Purchase accounting adjustments (1)
1.8
2.1
ASC 606 adoption impact
0.1
0.1
Equity in earnings of unconsolidated affiliates, net
(3.9
)
(2.3
)
Foreign currency translation losses
1.4
2.2
Investment losses (2)
0.5
1.8
Facilities and workforce restructuring
9.2
7.1
Acquisition related (3)
0.9
1.3
Other (4)
0.5
1.9
Income tax effect (5)
(44.8
)
(58.3
)
Adjusted net income
$
418.9
$
377.4
Adjusted net income attributable to noncontrolling interest (6)
(1.2
)
(1.3
)
Adjusted net income attributable to SS&C common stockholders
$
417.7
$
376.1
Adjusted diluted earnings per share attributable to SS&C common stockholders
$
1.69
$
1.48
GAAP diluted earnings per share attributable to SS&C common stockholders
$
0.91
$
0.84
Diluted weighted-average shares outstanding
247.6
254.9
(1)
Purchase accounting adjustments include (a) an adjustment to increase revenues by the amount that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisition, (b) an adjustment to increase personnel and commissions expense by the amount that would have been recognized if prepaid commissions and deferred personnel costs were not adjusted to fair value at the date of the acquisitions and (c) an adjustment to decrease depreciation expense by the amount that would not have been recognized if property, plant and equipment were not adjusted to fair value at the date of acquisition.
(2)
Investment gains includes unrealized fair value adjustments of investments. In prior periods, investment gains also included dividend income received on investments. Prior period amounts have been revised for consistent presentation.
(3)
Acquisition related includes costs related to both current acquisitions and the resolution of pre-acquisition matters for prior period acquisitions.
(4)
Other includes additional expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance.
(5)
An estimated effective tax rate of 22.5% has been used to adjust the provision for income taxes for the purpose of computing adjusted net income for the three months ended March 31, 2026. An effective tax rate of 22% has been used to retroactively adjust the provision for income taxes for the purpose of computing adjusted net income for the three months ended March 31, 2025.
(6)
In 2021, we entered into a joint venture named DomaniRx, LLC in which we are the majority interest holder and primary beneficiary. As such, we consolidate DomaniRx, LLC as a variable interest entity. Adjusted net income attributable to noncontrolling interest represents adjusted net income based on the ownership interest retained by the respective noncontrolling parties.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260423879573/en/
For more information
Brian Schell
Chief Financial Officer
Tel: +1-816-642-0915
E-mail: InvestorRelations@sscinc.com
Justine Stone
Head of Investor Relations
Tel: +1-212-367-4705
E-mail: InvestorRelations@sscinc.com
Chand Madaka
Investor Relations
Tel: +1-908-845-1259
E-mail: InvestorRelations@sscinc.com
Original: SS&C Technologies Releases Q1 2026 Financial Results
US Market News
4月前
SS&C Technologies Releases Record Q4 and Full Year 2025 Financial ResultsFebruary 5, 2026 4:05 PM
Business Wire
Q4 2025 GAAP revenue $1,653.5 million, up 8.1%, Fully Diluted GAAP Earnings Per Share $0.77, down 21.4%
Record adjusted revenue $1,654.6 million, up 8.1%, Adjusted Diluted Earnings Per Share $1.69, up 18.2%
SS&C Technologies Holdings, Inc. (NASDAQ: SSNC), a global provider of investment, financial and healthcare software and software-enabled services, today announced its financial results for the fourth quarter and full year ended December 31, 2025.
Three Months Ended
December 31,
Twelve Months Ended
December 31,
(in millions, except per share data):
2025
2024
Change
2025
2024
Change
GAAP Results
Revenue
$1,653.5
$1,529.7
8.1%
$6,272.2
$5,882.0
6.6%
Operating income
368.6
357.9
3.0%
1,436.7
1,343.5
6.9%
Operating income margin
22.3%
23.4%
-110 bps
22.9%
22.8%
10 bps
Diluted earnings per share attributable to SS&C
$0.77
$0.98
(21.4)%
$3.15
$3.00
5.0%
Net income attributable to SS&C
193.1
248.2
(22.2)%
796.9
760.5
4.8%
Adjusted Non-GAAP Results (defined in Notes 1 - 4 below)
Adjusted revenue
$1,654.6
$1,530.7
8.1%
$6,276.2
$5,885.7
6.6%
Adjusted operating income attributable to SS&C
634.2
581.9
9.0%
2,395.5
2,212.4
8.3%
Adjusted operating income margin
38.3%
38.0%
30 bps
38.2%
37.6%
60 bps
Adjusted diluted earnings per share attributable to SS&C (1)
$1.69
$1.43
18.2%
$6.14
$5.41
13.5%
Adjusted consolidated EBITDA attributable to SS&C
651.0
599.1
8.7%
2,462.3
2,281.0
7.9%
Adjusted consolidated EBITDA margin
39.3%
39.1%
20 bps
39.2%
38.8%
40 bps
(1) Reflects non-GAAP tax rates of 19.2% and 22.0% for the three and twelve months ended December 31, 2025, respectively, and 23.1% for the three and twelve months ended December 31, 2024. See Note 4 for more information.
Fourth Quarter and Full Year 2025 Highlights:
Q4 2025 GAAP Revenue growth and Adjusted Revenue growth were 8.1 percent.
Q4 and FY 2025 Adjusted Organic Revenue Growth were 5.3 and 4.8 percent, respectively.
Net cash generated from operating activities of $1,744.8 million for the twelve months ended December 31, 2025, up 25.7 percent compared to the same period in 2024.
Returned $384.2 million to shareholders in Q4 2025, which included 3.7 million shares repurchased for $318.7 million and $65.5 million in common stock dividends.
Allocated over $1 billion in share repurchases in 2025, purchasing 12.3 million shares at an average price of $84.12 per share.
Adjusted consolidated EBITDA attributable to SS&C of $651.0 million for Q4 2025, up 8.7 percent. Adjusted consolidated EBITDA margin for Q4 2025 was 39.3 percent.
GAAP operating income margin for Q4 2025 was 22.3 percent and GAAP net income attributable to SS&C of $193.1 million for Q4 2025, down 22.2 percent.
“SS&C’s 2025 performance reflects exceptional execution and the depth and breadth of our product and service portfolio. This quarter, we delivered record adjusted revenues of $1,655 million and adjusted consolidated EBITDA of $651 million, setting us up for a strong 2026,” says Bill Stone, Chairman and Chief Executive Officer. “AI advancements are rapidly reshaping the vertical software landscape. Our deep expertise and proprietary technology create a unique, deep and wide moat. This protective moat gives us time and perspective to leverage these innovations to drive long-term value.”
Operating Cash Flow
SS&C generated net cash from operating activities of $1,744.8 million for the twelve months ended December 31, 2025, compared to $1,388.6 million for the same period in 2024, a 25.7% increase. SS&C ended the fourth quarter with $462.1 million in cash and cash equivalents and $7,473.2 million in gross debt. SS&C’s consolidated net leverage ratio as defined in our credit agreement stood at 2.80 times consolidated EBITDA attributable to SS&C as of December 31, 2025. SS&C’s net secured leverage ratio stood at 1.70 times consolidated EBITDA attributable to SS&C as of December 31, 2025.
Guidance
Q1 2026
FY 2026
Adjusted Revenue ($M)
$1,608 – $1,648
$6,654 – $6,814
Adjusted Net Income attributable to SS&C ($M)
$404 – $420
$1,662 – $1,762
Interest Expense1 ($M)
$102 – $104
$398 – $408
Adjusted Diluted Earnings per Share attributable to SS&C
$1.62 – $1.68
$6.70 – $7.02
Cash from Operating Activities ($M)
–
$1,713 – $1,813
Capital Expenditures (% of revenue)
–
4.4% – 4.8%
Diluted Shares (M)
249.2 – 250.2
248.1 – 251.1
Effective Income Tax Rate (%)
21.5% – 23.5%
21.5% – 23.5%
1Interest expense is net of deferred financing cost amortization and original issue discount
SS&C does not provide reconciliations of guidance for Adjusted Revenues and Adjusted Net Income to comparable GAAP measures, in reliance on the unreasonable efforts exception provided under Item 10(e)(1)(i)(B) of Regulation S-K. SS&C is unable, without unreasonable efforts, to forecast certain items required to develop meaningful comparable GAAP financial measures. These items include acquisition transactions and integration, foreign exchange rate changes, as well as other non-cash and other adjustments as defined under the Company’s Credit agreement, that are difficult to predict in advance in order to include in a GAAP estimate. The unavailable information could have a significant impact on Q1 2026 and FY 2026 GAAP financial results.
Non-GAAP Financial Measures
Adjusted revenue, adjusted operating income, adjusted consolidated EBITDA, adjusted net income and adjusted diluted earnings per share are non-GAAP measures. See the accompanying notes for the reconciliations and definitions for each of these non-GAAP measures and the reasons our management believes these measures provide useful information to investors regarding our financial condition and results of operations.
Earnings Call and Press Release
SS&C’s fourth quarter and full year 2025 earnings call will take place at 5:00 p.m. eastern time today, February 5, 2026. The call will discuss fourth quarter and full year 2025 results and 2026 guidance. Interested parties may dial 888-210-4650 (US and Canada) or 646-960-0327 (International) and request the "SS&C Technologies Fourth Quarter and Full Year 2025 Earnings Conference Call"; conference ID #4673675. In connection with the earnings call, a presentation will be available on SS&C’s website at www.ssctech.com. The call will be available for replay via the webcast on SS&C’s website; access: https://investor.ssctech.com/financials/quarterly-results/default.aspx
Certain information contained in this press release, including information relating to, among other things, the Company’s financial guidance for the first quarter and full year of 2026 constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, expectations, intentions, projections, developments, future events, performance, underlying assumptions, and other statements that are other than statements of historical facts. Without limiting the foregoing, the words “believes”, “anticipates”, “plans”, “expects”, “estimates”, “projects”, “forecasts”, “may”, “assume”, “intend”, “will”, “continue”, “opportunity”, “predict”, “potential”, “future”, “guarantee”, “likely”, “target”, “indicate”, “would”, “could” and “should” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements are accompanied by such words. Such statements reflect management’s best judgment based on factors currently known but are subject to risks and uncertainties, which could cause actual results to differ materially from those anticipated. Such risks and uncertainties include, but are not limited to, the state of the economy and the financial services industry and other industries in which the Company’s clients operate, the Company’s ability to realize anticipated benefits from its acquisitions, the effect of customer consolidation on demand for the Company’s products and services, the variability of revenue as a result of activity in the securities markets, the focus of the Company’s business on the asset management industry, the ability to retain and attract clients, the intensity of competition with respect to the Company’s products and services, risks from cyber-attacks, breaches of digital security, IT system failures and network disruptions, risks associated with third party providers, fluctuations in the Company’s operating results, terrorist activities and other catastrophic events, risks associated with the Company’s foreign operations, privacy concerns relating to the collection and storage of personal information, evolving regulations and increased scrutiny from regulators, the Company’s ability to protect intellectual property assets and litigation regarding intellectual property rights, delays in product development, investment decisions concerning cash balances, tax risks, risks associated with the Company’s joint ventures, changes in accounting standards, evolving regulation and scrutiny from regulators, the Company’s exposure to litigation and other claims, risks related to the Company’s substantial indebtedness, and the market price of the Company’s stock prevailing from time to time, and the risks discussed in the “Risk Factors” section of the Company’s most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, which are on file with the Securities and Exchange Commission and can also be accessed on our website. Such “Risk Factors”, among others, could cause actual results to differ materially from those indicated by forward-looking statements made herein and presented elsewhere by management from time to time. Undue reliance should not be placed on any such forward-looking statements. Forward-looking statements speak only as of the date on which they are made and, except to the extent required by applicable securities laws, we undertake no obligation to update or revise any forward-looking statements.
About SS&C Technologies
SS&C is a global provider of services and software for the financial services and healthcare industries. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has offices around the world. More than 23,000 financial services and healthcare organizations, from the world's largest companies to small and mid-market firms, rely on SS&C for expertise, scale, and technology.
Follow SS&C on X, LinkedIn and Facebook.
SS&C Technologies Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Comprehensive Income
(in millions, except per share data)
(unaudited)
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2025
2024
2025
2024
Revenues:
Software-enabled services
$
1,364.1
$
1,254.0
$
5,211.1
$
4,840.3
License, maintenance and related
289.4
275.7
1,061.1
1,041.7
Total revenues
1,653.5
1,529.7
6,272.2
5,882.0
Cost of revenues:
Software-enabled services
763.9
669.1
2,839.3
2,618.8
License, maintenance and related
99.8
106.7
411.3
399.6
Total cost of revenues
863.7
775.8
3,250.6
3,018.4
Gross profit
789.8
753.9
3,021.6
2,863.6
Operating expenses:
Selling and marketing
175.6
156.6
625.0
584.2
Research and development
131.7
136.8
507.5
517.7
General and administrative
113.9
102.6
452.4
418.2
Total operating expenses
421.2
396.0
1,584.9
1,520.1
Operating income
368.6
357.9
1,436.7
1,343.5
Interest expense, net
(111.4
)
(113.0
)
(426.3
)
(451.9
)
Other (expense) income, net
(34.4
)
(7.6
)
(23.0
)
8.9
Equity in earnings of unconsolidated affiliates, net
(1.6
)
3.7
(9.3
)
24.4
Loss on extinguishment of debt
(1.1
)
(1.1
)
(3.3
)
(31.2
)
Income before income taxes
220.1
239.9
974.8
893.7
Provision (benefit) for income taxes
26.1
(8.5
)
176.1
132.0
Net income
194.0
248.4
798.7
761.7
Net income attributable to noncontrolling interest
(0.9
)
(0.2
)
(1.8
)
(1.2
)
Net income attributable to SS&C common stockholders
$
193.1
$
248.2
$
796.9
$
760.5
Basic earnings per share attributable to SS&C common stockholders
$
0.80
$
1.01
$
3.26
$
3.09
Diluted earnings per share attributable to SS&C common stockholders
$
0.77
$
0.98
$
3.15
$
3.00
Basic weighted-average number of common shares outstanding
242.8
246.0
244.3
246.4
Diluted weighted-average number of common and common equivalent shares outstanding
251.5
254.5
253.1
253.8
Net income
$
194.0
$
248.4
$
798.7
$
761.7
Other comprehensive income (loss), net of tax:
Foreign currency exchange translation adjustment
21.7
(229.2
)
255.6
(115.1
)
Change in defined benefit pension obligation
(8.6
)
0.1
(8.6
)
0.2
Total other comprehensive income (loss), net of tax
13.1
(229.1
)
247.0
(114.9
)
Comprehensive income
207.1
19.3
1,045.7
646.8
Comprehensive income attributable to noncontrolling interest
(0.9
)
(0.2
)
(1.8
)
(1.2
)
Comprehensive income attributable to SS&C common stockholders
$
206.2
$
19.1
$
1,043.9
$
645.6
SS&C Technologies Holdings, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in millions)
(unaudited)
December 31,
December 31,
2025
2024
Assets
Current assets:
Cash and cash equivalents
$
462.1
$
567.1
Funds receivable and funds held on behalf of clients
3,799.5
3,162.2
Accounts receivable, net
978.7
902.0
Contract asset
49.2
47.6
Prepaid expenses and other current assets
193.7
179.8
Restricted cash
4.5
3.7
Total current assets
5,487.7
4,862.4
Property, plant and equipment, net
289.5
299.6
Operating lease right-of-use assets
233.3
190.6
Investments
174.4
177.4
Unconsolidated affiliates
307.7
328.4
Contract asset
133.1
110.2
Goodwill
9,991.3
9,218.1
Intangible and other assets, net
4,094.7
3,858.0
Total assets
$
20,711.7
$
19,044.7
Liabilities and Equity
Current liabilities:
Current portion of long-term debt
$
25.0
$
20.0
Client funds obligations
3,799.5
3,162.2
Accounts payable
87.2
70.2
Income taxes payable
23.3
23.0
Accrued employee compensation and benefits
348.9
311.5
Interest payable
31.6
31.6
Other accrued expenses
303.4
249.7
Deferred revenue
492.4
486.1
Total current liabilities
5,111.3
4,354.3
Long-term debt, net of current portion
7,408.4
6,989.6
Operating lease liabilities
213.2
175.1
Other long-term liabilities
190.2
191.1
Deferred income taxes
846.8
725.5
Total liabilities
13,769.9
12,435.6
SS&C stockholders' equity
6,887.6
6,534.9
Noncontrolling interest
54.2
74.2
Total equity
6,941.8
6,609.1
Total liabilities and equity
$
20,711.7
$
19,044.7
SS&C Technologies Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(in millions)
(unaudited)
Twelve Months Ended December 31,
2025
2024
Cash flow from operating activities:
Net income
$
798.7
$
761.7
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
703.8
680.1
Equity in earnings of unconsolidated affiliates, net
9.3
(24.4
)
Distributions received from unconsolidated affiliates
2.6
13.1
Stock-based compensation expense
257.7
203.3
Unrealized net losses (gains) on investments
3.4
(1.7
)
Amortization of debt financing costs
6.8
8.4
Loss on extinguishment of debt
3.3
31.2
Loss on sale or disposition of property and equipment
35.1
1.6
Deferred income taxes
(17.4
)
(115.4
)
Provision for credit losses
18.6
15.4
Changes in operating assets and liabilities, excluding effects from acquisitions:
Accounts receivable
(46.0
)
(119.1
)
Prepaid expenses and other assets
(6.6
)
(20.7
)
Contract assets
(20.2
)
(25.1
)
Accounts payable
14.1
(10.7
)
Accrued expenses and other liabilities
9.9
(16.5
)
Income taxes prepaid and payable
(14.6
)
(13.8
)
Deferred revenue
(13.7
)
21.2
Net cash provided by operating activities
1,744.8
1,388.6
Cash flow from investing activities:
Business acquisitions, net of cash acquired
(1,052.0
)
(647.1
)
Additions to property and equipment
(80.8
)
(61.4
)
Proceeds from sale of property and equipment
17.8
4.8
Additions to capitalized software
(221.9
)
(194.3
)
Investments in securities
(2.5
)
(0.1
)
Proceeds from sales / maturities of investments
0.8
6.9
Distributions received from unconsolidated affiliates
20.5
25.3
Collection of other non-current receivables
10.5
10.2
Net cash used in investing activities
(1,307.6
)
(855.7
)
Cash flow from financing activities:
Cash received from debt borrowings
1,187.0
5,545.0
Repayments of debt
(765.1
)
(5,255.1
)
Payment of deferred financing fees
(7.6
)
(39.4
)
Net increase in client funds obligations
307.5
235.8
Proceeds from exercise of stock options
425.5
355.1
Withholding taxes paid related to equity award net share settlement
(79.2
)
(26.2
)
Purchases of common stock for treasury
(1,036.0
)
(737.5
)
Dividends paid on common stock
(253.8
)
(244.9
)
(Distributions to) proceeds from noncontrolling interests
(21.8
)
14.9
Net cash used in financing activities
(243.5
)
(152.3
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
9.6
(8.7
)
Net increase in cash, cash equivalents and restricted cash
203.3
371.9
Cash, cash equivalents and restricted cash and cash equivalents, beginning of period
3,370.5
2,998.6
Cash, cash equivalents and restricted cash and cash equivalents, end of period
$
3,573.8
$
3,370.5
Reconciliation of cash, cash equivalents and restricted cash and cash equivalents:
Cash and cash equivalents
$
462.1
$
567.1
Restricted cash and cash equivalents
4.5
3.7
Restricted cash and cash equivalents included in funds receivable and funds held on behalf of clients
3,107.2
2,799.7
$
3,573.8
$
3,370.5
SS&C Technologies Holdings, Inc. and Subsidiaries
Disclosures Relating to Non-GAAP Financial Measures
Note 1. Reconciliation of Revenues to Adjusted Revenues
Adjusted revenues represents revenues adjusted to include a) amounts that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisition and b) amounts that would have been recognized if not for adjustments to deferred revenue and retained earnings related to the adoption of ASC 606. Adjusted revenues is presented because we use this measure to evaluate performance of our business against prior periods and believe it is a useful indicator of the underlying performance of our business. Adjusted revenues is not a recognized term under generally accepted accounting principles (“GAAP”). Adjusted revenues does not represent revenues, as that term is defined under GAAP, and should not be considered as an alternative to revenues as an indicator of our operating performance. Adjusted revenues as presented herein is not necessarily comparable to similarly titled measures presented by other companies. Below is a reconciliation of adjusted revenues to revenues, the GAAP measure we believe to be most directly comparable to adjusted revenues.
Three Months Ended
December 31,
Twelve Months Ended
December 31,
(in millions)
2025
2024
2025
2024
Revenues
$
1,653.5
$
1,529.7
$
6,272.2
$
5,882.0
ASC 606 adoption impact
—
—
—
(2.2
)
Purchase accounting adjustments impact on revenue
1.1
1.0
4.0
5.9
Adjusted revenues
$
1,654.6
$
1,530.7
$
6,276.2
$
5,885.7
The following is a breakdown of software-enabled services and license, maintenance and related revenues and adjusted software-enabled services and license, maintenance and related revenues.
Three Months Ended
December 31,
Twelve Months Ended
December 31,
(in millions)
2025
2024
2025
2024
Software-enabled services
$
1,364.1
$
1,254.0
$
5,211.1
$
4,840.3
License, maintenance and related
289.4
275.7
1,061.1
1,041.7
Total revenues
$
1,653.5
$
1,529.7
$
6,272.2
$
5,882.0
Software-enabled services
$
1,365.2
$
1,254.9
$
5,215.1
$
4,844.0
License, maintenance and related
289.4
275.8
1,061.1
1,041.7
Total adjusted revenues
$
1,654.6
$
1,530.7
$
6,276.2
$
5,885.7
Note 2. Reconciliation of Operating Income to Adjusted Operating Income
Adjusted operating income represents operating income adjusted for amortization of intangible assets, stock-based compensation, purchase accounting adjustments for deferred revenue and related costs, ASC 606 adoption impact and other expenses. Adjusted operating income is presented because we use this measure to evaluate performance of our business and believe it is a useful indicator of our underlying performance. Adjusted operating income is not a recognized term under GAAP. Adjusted operating income does not represent operating income, as that term is defined under GAAP, and should not be considered as an alternative to operating income as an indicator of our operating performance. Adjusted operating income as presented herein is not necessarily comparable to similarly titled measures by other companies. The following is a reconciliation between adjusted operating income and operating income, the GAAP measure we believe to be most directly comparable to adjusted operating income.
Three Months Ended
December 31,
Twelve Months Ended
December 31,
(in millions)
2025
2024
2025
2024
Operating income
$
368.6
$
357.9
$
1,436.7
$
1,343.5
Amortization of intangible assets
164.7
157.5
632.5
606.6
Stock-based compensation
84.8
55.4
257.7
203.3
Purchase accounting adjustments (1)
2.1
2.1
8.8
11.6
ASC 606 adoption impact
0.1
0.1
0.4
(1.9
)
Acquisition related (2)
5.4
0.5
11.5
3.2
Facilities and workforce restructuring
8.9
8.0
45.1
41.6
Other (3)
0.4
1.4
6.0
8.6
Adjusted operating income
$
635.0
$
582.9
$
2,398.7
$
2,216.5
Adjusted operating income attributable to noncontrolling interest (4)
(0.8
)
(1.0
)
(3.2
)
(4.1
)
Adjusted operating income attributable to SS&C common stockholders
$
634.2
$
581.9
$
2,395.5
$
2,212.4
(1)
Purchase accounting adjustments include (a) an adjustment to increase revenues by the amount that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisition, (b) an adjustment to increase personnel and commissions expense by the amount that would have been recognized if prepaid commissions and deferred personnel costs were not adjusted to fair value at the date of the acquisitions and (c) an adjustment to decrease depreciation expense by the amount that would not have been recognized if property, plant and equipment were not adjusted to fair value at the date of acquisition.
(2)
Acquisition related includes costs related to both current acquisitions and the resolution of pre-acquisition matters for prior period acquisitions.
(3)
Other includes additional expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance.
(4)
In 2021, we entered into a joint venture named DomaniRx, LLC in which we are the majority interest holder and primary beneficiary. As such, we consolidate DomaniRx, LLC as a variable interest entity. Adjusted operating income attributable to noncontrolling interest represents adjusted operating income based on the ownership interest retained by the respective noncontrolling parties.
Note 3. Reconciliation of Net Income to EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA
EBITDA represents net income before interest expense, income taxes, depreciation and amortization. Consolidated EBITDA, defined under our Credit Agreement entered into in April 2018, as amended, is used in calculating covenant compliance, and is EBITDA adjusted for certain items. Consolidated EBITDA is calculated by subtracting from or adding to EBITDA items of income or expense described below. Adjusted Consolidated EBITDA is calculated by subtracting acquired EBITDA (as defined below) from Consolidated EBITDA. EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA are presented because we use these measures to evaluate performance of our business and believe them to be useful indicators of an entity’s debt capacity and its ability to service debt. EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA are not recognized terms under GAAP and should not be considered in isolation or as alternatives to operating income, net income or cash flows from operating activities as indicators of our operating performance. These measures are not necessarily comparable to similarly titled measures by other companies. The following is a reconciliation of EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA to net income.
Three Months Ended
December 31,
Twelve Months Ended
December 31,
(in millions)
2025
2024
2025
2024
Net income
$
194.0
$
248.4
$
798.7
$
761.7
Interest expense, net
111.4
113.0
426.3
451.9
Provision for income taxes
26.1
(8.5
)
176.1
132.0
Depreciation and amortization
182.7
175.8
703.8
680.1
EBITDA
514.2
528.7
2,104.9
2,025.7
Stock-based compensation
84.8
55.4
257.7
203.3
Acquired EBITDA and cost savings (1)
2.8
—
42.5
19.4
Loss on extinguishment of debt
1.1
1.1
3.3
31.2
Equity in earnings of unconsolidated affiliates, net
1.6
(3.7
)
9.3
(24.4
)
Purchase accounting adjustments (2)
1.1
1.1
4.4
6.8
ASC 606 adoption impact
0.1
0.1
0.4
(1.9
)
Foreign currency translation losses
0.9
6.6
1.8
8.2
Investment gains (3)
(0.5
)
(2.3
)
(14.0
)
(19.6
)
Facilities and workforce restructuring
8.9
7.8
45.1
41.4
Acquisition related (4)
4.7
0.6
11.5
3.3
Other (5)
34.9
4.7
41.1
11.1
Consolidated EBITDA
$
654.6
$
600.1
$
2,508.0
$
2,304.5
Acquired EBITDA and cost savings (1)
(2.8
)
—
(42.5
)
(19.4
)
Adjusted Consolidated EBITDA
$
651.8
$
600.1
$
2,465.5
$
2,285.1
Adjusted Consolidated EBITDA attributable to noncontrolling interest (6)
(0.8
)
(1.0
)
(3.2
)
(4.1
)
Adjusted Consolidated EBITDA attributable to SS&C common stockholders
$
651.0
$
599.1
$
2,462.3
$
2,281.0
(1)
Acquired EBITDA reflects the EBITDA impact of significant businesses that were acquired during the period as if the acquisition occurred at the beginning of the period, as well as cost savings enacted in connection with acquisitions.
(2)
Purchase accounting adjustments include (a) an adjustment to increase revenues by the amount that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisitions (b) an adjustment to increase personnel and commissions expense by the amount that would have been recognized if prepaid commissions and deferred personnel costs were not adjusted to fair value at the date of the acquisitions and (c) an adjustment to increase or decrease rent expense by the amount that would have been recognized if lease obligations were not adjusted to fair value at the date of acquisitions.
(3)
Investment gains includes unrealized fair value adjustments of investments and dividend income received on investments.
(4)
Acquisition related includes costs related to both current acquisitions and the resolution of pre-acquisition matters for prior period acquisitions.
(5)
Other includes additional expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance, and includes a loss on the sale of fixed assets of $33.3 million during the three and twelve months ended December 31, 2025.
(6)
In 2021, we entered into a joint venture named DomaniRx, LLC in which we are the majority interest holder and primary beneficiary. As such, we consolidate DomaniRx, LLC as a variable interest entity. Adjusted Consolidated EBITDA attributable to noncontrolling interest represents adjusted Consolidated EBITDA based on the ownership interest retained by the respective noncontrolling parties.
Note 4. Reconciliation of Net Income to Adjusted Net Income and Diluted Earnings Per Share Attributable to SS&C to Adjusted Diluted Earnings Per Share Attributable to SS&C
Adjusted net income and adjusted diluted earnings per share attributable to SS&C represent net income and earnings per share attributable to SS&C before amortization of intangible assets and deferred financing costs, stock-based compensation, purchase accounting adjustments and other items. We consider adjusted net income and adjusted diluted earnings per share attributable to SS&C to be important to management and investors because they represent our operational performance exclusive of the effects of amortization of intangible assets and deferred financing costs, stock-based compensation, purchase accounting adjustments, loss on extinguishment of debt and other items, that are not operational in nature or comparable to those of our competitors. Adjusted net income and adjusted diluted earnings per share are not recognized terms under GAAP. Adjusted net income and adjusted diluted earnings per share do not represent net income or diluted earnings per share, as those terms are defined under GAAP, and should not be considered as alternatives to net income or diluted earnings per share as indicators of our operating performance. Adjusted net income and adjusted diluted earnings per share attributable to SS&C as presented herein are not necessarily comparable to similarly titled measures presented by other companies. Below is a reconciliation of adjusted net income and adjusted diluted earnings per share attributable to SS&C to net income and diluted earnings per share attributable to SS&C, the GAAP measures we believe to be most directly comparable to adjusted net income and adjusted diluted earnings per share.
Three Months Ended
December 31,
Twelve Months Ended
December 31,
(in millions, except per share data)
2025
2024
2025
2024
GAAP – Net income
$
194.0
$
248.4
$
798.7
$
761.7
Amortization of intangible assets
164.7
157.5
632.5
606.6
Amortization of debt financing costs
1.9
1.7
6.8
8.4
Stock-based compensation
84.8
55.4
257.7
203.3
Loss on extinguishment of debt
1.1
1.1
3.3
31.2
Purchase accounting adjustments (1)
2.1
2.1
8.8
11.6
ASC 606 adoption impact
0.1
0.1
0.4
(1.9
)
Equity in earnings of unconsolidated affiliates, net
1.6
(3.7
)
9.3
(24.4
)
Foreign currency translation losses
0.9
6.6
1.8
8.2
Investment losses (gains) (2)
1.0
0.9
3.4
(1.6
)
Facilities and workforce restructuring
8.9
7.8
45.1
41.4
Acquisition related (3)
4.7
0.6
11.5
3.3
Other (4)
35.0
4.9
41.1
11.2
Income tax effect (5)
(75.1
)
(118.3
)
(263.1
)
(281.9
)
Adjusted net income
$
425.7
$
365.1
$
1,557.3
$
1,377.1
Adjusted net income attributable to noncontrolling interest (6)
(0.9
)
(1.4
)
(4.1
)
(5.0
)
Adjusted net income attributable to SS&C common stockholders
$
424.8
$
363.7
$
1,553.2
$
1,372.1
Adjusted diluted earnings per share attributable to SS&C common stockholders
$
1.69
$
1.43
$
6.14
$
5.41
GAAP diluted earnings per share attributable to SS&C common stockholders
$
0.77
$
0.98
$
3.15
$
3.00
Diluted weighted-average shares outstanding
251.5
254.5
253.1
253.8
(1)
Purchase accounting adjustments include (a) an adjustment to increase revenues by the amount that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisition, (b) an adjustment to increase personnel and commissions expense by the amount that would have been recognized if prepaid commissions and deferred personnel costs were not adjusted to fair value at the date of the acquisitions and (c) an adjustment to decrease depreciation expense by the amount that would not have been recognized if property, plant and equipment were not adjusted to fair value at the date of acquisition.
(2)
Investment gains includes unrealized fair value adjustments of investments. In prior periods, investment gains also included dividend income received on investments. Prior period amounts have been revised for consistent presentation.
(3)
Acquisition related includes costs related to both current acquisitions and the resolution of pre-acquisition matters for prior period acquisitions.
(4)
Other includes additional expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance, and includes a loss on the sale of fixed assets of $33.3 million during the three and twelve months ended December 31, 2025.
(5)
For the twelve-month period ending December 31, 2025, we revised the effective tax rate used to adjust the provision for income taxes for the purpose of computing adjusted net income to 22.0% from 23.0%. The change in this effective tax rate is attributable to increased deductions related to equity awards, positive impacts from the tax bill signed in July 2025, and implementation of strategic planning initiatives. As a result, an effective tax rate of 19.2% for the three months ended December 31, 2025, has been used to adjust the provision for income taxes for the purpose of computing adjusted net income. An effective tax rate of 23.1% has been used for the three and twelve months ended December 31, 2024.
(6)
In 2021, we entered into a joint venture named DomaniRx, LLC in which we are the majority interest holder and primary beneficiary. As such, we consolidate DomaniRx, LLC as a variable interest entity. Adjusted net income attributable to noncontrolling interest represents adjusted net income based on the ownership interest retained by the respective noncontrolling parties.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260205784330/en/
For more information
Brian Schell
Chief Financial Officer
Tel: +1-816-642-0915
E-mail: InvestorRelations@sscinc.com
Justine Stone
Head of Investor Relations
Tel: +1-212-367-4705
E-mail: InvestorRelations@sscinc.com
Chand Madaka
Investor Relations
Tel: +1-908-845-1259
E-mail: InvestorRelations@sscinc.com
Original: SS&C Technologies Releases Record Q4 and Full Year 2025 Financial Results
Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
ranchhand71
5年前
fung_derf
7年前
Penny Roger$
14年前
メールアドレスで登録
